MRI Study of OnabotulinumtoxinA (OnabotA) Effect on Jaw Muscle Pain
MRI-based Comparison of OnabotulinumtoxinA (OnabotA) Versus Placebo Injections to the Temporalis and Masseter Muscles in the Management of Myofascial Pain Syndrome: A Randomized Clinical Trial
The goal of this clinical trial is to learn which magnetic resonance images are best able to assess and predict if a participant with masticatory myofascial pain syndrome will benefit from Botox injections, as compared to placebo (saline, salt water).
The main questions the study aims to answer are:
- Will diffusion MR images will be best able to assess and predict if a participant with masticatory myofascial pain syndrome will benefit from Botox injections?
- Will Botox injections reduce masticatory myofascial pain and improve jaw function?
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 2
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Peter Chernek
- Telefonnummer: 646-962-5951
- E-mail: pec4005@med.cornell.edu
Studiesteder
-
-
New York
-
New York, New York, Forenede Stater, 10065
- Weill Cornell Medicine
-
Kontakt:
- Peter Chernek
- Telefonnummer: 646-962-5951
- E-mail: pec4005@med.cornell.edu
-
Ledende efterforsker:
- Gwendolyn Reeve, D.M.D., FACS
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Participant is at least 18 years of age
- Participant has a unilateral or bilateral myofascial pain diagnosis according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD), diagnosed by a provider
Exclusion Criteria:
- Participant is pregnant, breastfeeding, or plans to become pregnant
- Participant has known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation
- Participant has received Botox within the past 4 months
- Participant cannot undergo an MRI. Reasons a participant cannot undergo MRIs for this study include having a pacemaker or having claustrophobia
- Participant has dental implants with metal on the same side/sides of their jaw pain
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Placebo komparator: Placebo-injektioner
|
4mL
Andre navne:
|
|
Aktiv komparator: Botox Injections
|
100 units/4mL.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change of muscle fiber diameter of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by Diffusion MRI in micrometers |
Baseline; 3 months
|
|
Change of muscle fiber permeability of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by Diffusion MRI in cm/sec |
Baseline; 3 months
|
|
Change of tissue diffusivity of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by Diffusion MRI in micrometer2/millisecond |
Baseline; 3 months
|
|
Change of pseudo-diffusivity of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by Diffusion MRI in micrometer2/millisecond |
Baseline; 3 months
|
|
Change of perfusion fraction of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by Diffusion MRI (no units) |
Baseline; 3 months
|
|
Change of T2 (transverse relaxation time) of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by MRI in milliseconds |
Baseline; 3 months
|
|
Change of T2* (effective transverse relaxation time) of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by MRI in milliseconds |
Baseline; 3 months
|
|
Change of FF (fat fraction) of jaw muscles between baseline and 3 month follow up.
Tidsramme: Baseline; 3 months
|
Measured by MRI (no units) |
Baseline; 3 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline in Visual Analog Scale Score at 1 month
Tidsramme: Baseline; 1 month
|
The Visual Analog Scale ranges from 0 to 10, where higher scores indicate more pain. |
Baseline; 1 month
|
|
Change from Baseline in Visual Analog Scale Score at 3 months
Tidsramme: Baseline; 3 months
|
The Visual Analog Scale ranges from 0 to 10, where higher scores indicate more pain. |
Baseline; 3 months
|
|
Change in jaw function, assessed by Jaw Function Limitation Score (JFLS) from baseline to 1 month.
Tidsramme: Baseline; 1 month
|
The Jaw Function Limitation Score (JFLS) ranges from 0 to 8, where higher scores indicate more limitation. |
Baseline; 1 month
|
|
Change in jaw function, assessed by Jaw Function Limitation Score (JFLS) from baseline to 3 months.
Tidsramme: Baseline; 3 months
|
The Jaw Function Limitation Score (JFLS) ranges from 0 to 8, where higher scores indicate more limitation. |
Baseline; 3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Gwendolyn Reeve, D.M.D., FACS, Weill Medical College of Cornell University
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Aminosyrer, peptider og proteiner
- Proteiner
- Biologiske faktorer
- Hydrolaser
- Enzymer
- Enzymer og coenzymer
- Uorganiske kemikalier
- Klorforbindelser
- Botulinumtoksiner
- Metalloendopeptidaser
- Endopeptidaser
- Peptidhydrolaser
- Metalloproteaser
- Bakterielle proteiner
- Bakterielle toksiner
- Toksiner, biologisk
- Natriumforbindelser
- Chlorider
- Hydrochlorsyre
- Botulinumtoksiner, type A
- Natriumchlorid
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 26-06030338
- R33AT012270 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
De-identified data and de-identified MR images
IPD-delingstidsramme
Start date - end of study End date - N/A
IPD-delingsadgangskriterier
Investigators who are approved by the NIH HEAL Initiative (Helping to End Addiction Long-Term) or the National Institutes of Health (NIH)
IPD-deling Understøttende informationstype
- ANALYTIC_CODE
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .